KRYS - Balance Sheet - Krystal Biotech, Inc.

Current Liabilities	102 M
Accounts Payable	4.98 M
Short-Term Debt	1.22 M
Other Current Liabilities	95.8 M
Non-Current Liabilities	7.46 M
Long-Term Debt	6.04 M
Other Non-Current Liabilities	1.42 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	344.9	358.3	161.9	341.2	268.3	187.5	103.7	49.6	1.9
Short Term Investments	252.7	173.8	217.3	96.8	3.0	6.2	8.1	0	0
Receivables	104.7	42.0	0	0	0	0	0	0	0
Inventory	26.5	7.0	0	0	0	0	0	0	0
Other Current Assets	13.3	6.7	4.6	8.3	7.6	4.4	1.8	0.3	0.2
Total Current Assets	742.0	587.9	383.8	442.3	275.1	195.9	112.7	49.9	2.2
PP&E	161.4	168.2	169.7	119.6	34.2	11.2	3.0	0.2	13 K
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	152.1	62.0	4.6	64.4	0	0.5	0	0	0
Other Long Term Assets	0.2	0.3	0.3	74 K	1.6	1.5	0.5	0	0
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	1 055.8	818.4	558.5	626.3	310.8	209.0	116.1	50.1	2.2
LIABILITIES
Accounts Payable	5.0	1.8	4.0	8.4	2.1	0.7	0.9	0.2	42 K
Short Term Debt	1.2	1.5	3.1	1.0	16.5	1.0	0	0	0
Other Current Liabilities	91.5	27.5	21.7	16.2	(3.2)	1.6	1.6	0.3	1 K
Total Current Liabilities	102.0	33.1	28.8	25.7	15.5	3.3	2.6	0.6	43 K
Long Term Debt	6.0	6.6	7.4	7.0	3.3	2.8	0	0	1.8
Deferred Tax Income	0	0	0	0	0	0	0	0	0
Other Liabilities	1.4	0	0	0	0	0	0.3	0	7 K
Total Liabilities	109.5	39.7	36.2	32.7	18.8	6.1	2.9	0.6	1.9
EQUITY
Common Stock	0	0	0	0	0	0	0	0	0
Retained Earnings	(180.7)	(269.8)	(280.8)	(140.8)	(71.2)	(39.0)	(20.0)	(9.1)	(1.1)
Other Accumulative Comprehensive Income/Loss	(0.2)	0.6	(0.7)	(0.2)	6 K	10 K	2 K	25 K	2 K
Total Equity	946.4	778.6	522.2	593.6	292.1	202.9	113.2	49.5	0.3
Total Liabilities and Equity	1 055.8	818.4	558.5	626.3	310.8	209.0	116.1	50.1	2.2
SHARES OUTSTANDING
Common Shares Outstanding	28.6	27.2	25.5	22.2	18.8	15.9	11.2	5.4	4.3

Free